Form 4 for VCYT VERACYTE, INC.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001384101-25-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-03 | 2025-02-27+ | VCYT | Stapley Marc | CEO, Dir | F - Tax | $34.18 | -54.6K | 341.1K | -14% | -$1.87M |
| 2025-03-03 | 2025-02-27 | VCYT | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +67.3K | 375.3K | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-02 | F | D | 20,324 | $34.76 | 320,732 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-27 | F | D | 34,273 | $33.84 | 341,056 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-27 | A | A | 67,277 | $0.00 | 375,329 | D | — | — | (F2) Includes 707 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |